Gallbladder carcinoma: prognostic factors and therapeutic options

被引:26
|
作者
Thorsten Oliver Goetze [1 ]
机构
[1] Institut of Clinical Cancer Research,UCT-University Cancer Center Frankfurt
关键词
Gallbladder carcinoma; Stage-adjusted therapy; Radical cholecystectomy; Gallbladder polyps; Cholecystitis; Gallstones; Laparoscopic cholecystectomy;
D O I
暂无
中图分类号
R735.8 [胆囊、胆道肿瘤];
学科分类号
100214 ;
摘要
The outcome of gallbladder carcinoma is poor,and the overall 5-year survival rate is less than 5%. In early-stage disease,a 5-year survival rate up to 75% can be achieved if stage-adjusted therapy is performed. There is wide geographic variability in the frequency of gallbladder carcinoma,which can only be explained by an interaction between genetic factors and their alteration. Gallstones and chronic cholecystitis are important risk factors in the formation of gallbladder malignancies. Factors such as chronic bacterial infection,primary sclerosing cholangitis,an anomalous junction of the pancreaticobiliary duct,and several types of gallbladder polyps are associated with a higher risk of gallbladder cancer. There is also an interesting correlation between risk factors and the histological type of cancer. However,despite theoretical risk factors,only a third of gallbladder carcinomas are recognized preoperatively. In most patients,the tumor is diagnosed by the pathologist after a routine cholecystectomy for a benign disease and is termed ‘‘incidental or occult gallbladder carcinoma’’(IGBC). A cholecystectomy is performed frequently due to the minimal invasiveness of the laparoscopic technique. Therefore,the postoperative diagnosis of potentially curable early-stage disease is more frequent. A second radical re-resection to complete a radical cholecystectomy is required for several IGBCs. However,the literature and guidelines used in different countries differ regarding the radicality or T-stage criteria for performing a radical cholecystectomy. The NCCN guidelines and data from the German registry(GR),which records the largest number of incidental gallbladder carcinomas in Europe,indicate that carcinomas infiltrating the muscularis propria or beyond require radical surgery. According to GR data and current literature,a wedge resection with a combined dissection of the lymph nodes of the hepatoduodenal ligament is adequate for T1 b and T2 carcinomas. The reason for a radical cholecystectomy after simple CE in a formally R0 situation is either occult invasion or hepatic spread with unknown lymphogenic dissemination. Unfortunately,there are diverse interpretations and practices regarding stageadjusted therapy for gallbladder carcinoma. The current data suggest that more radical therapy is warranted.
引用
收藏
页码:12211 / 12217
页数:7
相关论文
共 50 条
  • [41] Therapeutic effect and prognostic factors of IMRT for primary large hepatocellular carcinoma
    Li, G.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S653 - S653
  • [42] THERAPEUTIC STRATEGIES IN INFLAMMATORY BREAST-CARCINOMA BASED ON PROGNOSTIC FACTORS
    ROUESSE, J
    FRIEDMAN, S
    MOURIESSE, H
    SARRAZIN, D
    SPIELMANN, M
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 (01) : 15 - 22
  • [43] THERAPEUTIC IMPLICATIONS OF PROGNOSTIC FACTORS IN DIFFERENTIATED CARCINOMA OF THE THYROID-GLAND
    LOREE, TR
    SEMINARS IN SURGICAL ONCOLOGY, 1995, 11 (03): : 246 - 255
  • [44] Surgical treatment of gallbladder carcinoma. Prognostic value of lymph nodes metastases in gallbladder carcinoma
    Bialek, P
    Biejat, Z
    Polanski, J
    2ND WORLD CONGRESS - INTERNATIONAL HEPATO-PANCREATO-BILIARY ASSOCIATION, VOL II: BILIARY-PANCREAS, 1996, : 877 - 881
  • [45] Hepatocellular Carcinoma: therapeutic options 2015
    Schultheiss, Michael
    Bettinger, Dominik
    Neeff, Hannes P.
    Brunner, Thomas B.
    Thimme, Robert
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1063 - +
  • [46] Localized hepatocellular carcinoma: Therapeutic options
    Ribeiro A.
    Nagorney D.M.
    Gores G.J.
    Current Gastroenterology Reports, 2000, 2 (1) : 72 - 81
  • [47] Therapeutic options for mucinous ovarian carcinoma
    Gorringe, Kylie L.
    Cheasley, Dane
    Wakefield, Matthew J.
    Ryland, Georgina L.
    Allan, Prue E.
    Alsop, Kathryn
    Amarasinghe, Kaushalya C.
    Ananda, Sumitra
    Bowtell, David D. L.
    Christie, Michael
    Chiew, Yoke-Eng
    Churchman, Michael
    DeFazio, Anna
    Fereday, Sian
    Gilks, C. Blake
    Gourley, Charlie
    Hadley, Alison M.
    Hendley, Joy
    Hunter, Sally M.
    Kaufmann, Scott H.
    Kennedy, Catherine J.
    Kobel, Martin
    Le Page, Cecile
    Li, Jason
    Lupat, Richard
    McNally, Orla M.
    McAlpine, Jessica N.
    Pyman, Jan
    Rowley, Simone M.
    Salazar, Carolina
    Saunders, Hugo
    Semple, Timothy
    Stephens, Andrew N.
    Thio, Niko
    Torres, Michelle C.
    Traficante, Nadia
    Zethoven, Magnus
    Antill, Yoland C.
    Campbell, Ian G.
    Scott, Clare L.
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 552 - 560
  • [48] GALLBLADDER CANCER - EPIDEMIOLOGY, DIAGNOSIS AND PROGNOSTIC FACTORS
    LAUNOY, G
    CRENESLAVENTURE, E
    DAO, T
    POTTIER, D
    ROUGEREAU, A
    VERWAEDE, JC
    GIGNOUX, M
    ANNALES DE CHIRURGIE, 1993, 47 (01): : 18 - 23
  • [49] Prognostic factors for gallbladder cancer in the laparoscopy era
    Lee, Hak Youn
    Kim, Young Hoon
    Jung, Ghap Joong
    Roh, Young Hoon
    Park, Si Young
    Kang, Nam Uk
    Yoon, Soon Hwa
    Cho, Jin Han
    Roh, Myung Hwan
    Han, Sang Young
    Lee, Sung Wook
    Baek, Yang Hyun
    Jeong, Jin Sook
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2012, 83 (04): : 227 - 236
  • [50] Prognostic factors in gallbladder and biliary tract cancer
    Xóchitl Gómez-Roel
    Oscar Arrieta
    Eucario León-Rodríguez
    Medical Oncology, 2007, 24 : 77 - 83